US equities |
MU $987.71 ▼-4.01% META $743.86 ▲+3.50% NVDA $226.45 ▼-1.23% SNDK $1,477.53 ▼-6.59% SPCX $163.90 ▲+0.82% AMD $590.68 ▼-2.86% MSFT $539.43 ▲+0.81% TSLA $378.37 ▼-1.13%
FinancialContent

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share (NQ:FOCL)

4.250 +0.060 (+1.43%)
Delayed Quote Updated: 2:41 PM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

News headline image
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026 
From FocalTherics (TM)
Via GlobeNewswire
News headline image
FocalTherics™ Reports Second Quarter 2026 Financial Results
39% Revenue Increase and 47% Growth in U.S. Procedures 
From FocalTherics (TM)
Via GlobeNewswire
News headline image
FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
From FocalTherics (TM)
Via GlobeNewswire
News headline image
FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026
From FocalTherics (TM)
Via GlobeNewswire
News headline image
FocalTherics™ Announces Proposed Public Offering of American Depositary Shares
From FocalTherics (TM)
Via GlobeNewswire
News headline image
FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
Company to host conference call and webcast on Thursday, August 13 at 4:30 p.m. EDT 
From FocalTherics (TM)
Via GlobeNewswire
News headline image
FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
From FocalTherics (TM)
Via GlobeNewswire
News headline image
FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical
From FocalTherics (TM)
Via GlobeNewswire